Epinephrine decreases the dose of hyperbaric bupivacaine necessary for tourniquet pain blockade during spinal anesthesia for total knee replacement arthroplasty

Purpose We quantified the dose-sparing effect of epinephrine by comparing the median effective dose (ED 50 ) of intrathecal hyperbaric bupivacaine co-administered with epinephrine with the ED 50 of intrathecal hyperbaric bupivacaine alone. Methods Three groups were randomly generated from 162 patien...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of anesthesia 2013-02, Vol.27 (1), p.72-79
Hauptverfasser: Kim, Won Ho, Ko, Justin Sangwook, Ahn, Hyun Joo, Choi, Soo Joo, Shin, Byung Seop, Gwak, Mi Sook, Sim, Woo Seog, Yang, Mikyung
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose We quantified the dose-sparing effect of epinephrine by comparing the median effective dose (ED 50 ) of intrathecal hyperbaric bupivacaine co-administered with epinephrine with the ED 50 of intrathecal hyperbaric bupivacaine alone. Methods Three groups were randomly generated from 162 patients undergoing total knee replacement arthroplasty under combined spinal and epidural anesthesia: Group B (bupivacaine), Group BE1 (bupivacaine plus epinephrine 100 μg), and Group BE2 (bupivacaine plus epinephrine 200 μg). Each group was further divided by bupivacaine doses of 6, 7, 8, 9, 10, or 11 mg. The anesthesia was defined as successful if a bilateral T12 sensory block occurred within 15 min, and no intraoperative epidural supplement was required. The ED 50 and ED 95 for successful anesthesia and successful tourniquet pain blockade were determined separately by probit regression analysis. Results The ED 50 and ED 95 of intrathecal hyperbaric bupivacaine for successful anesthesia were not different among the groups: the ED 50 values were 7.1 mg [95 % confidence interval (95 % CI) 6.0–8.0 mg] in Group B, 6.2 mg (95 % CI 4.8–7.2 mg) in Group BE1, and 6.3 mg (95 % CI 4.9–7.2 mg) in Group BE2. However, the ED 50 and ED 95 values for tourniquet pain control were significantly smaller in Groups BE1 and BE2 than in Group B: the ED 50 values were 7.2 mg (95 % CI 6.3–7.9 mg), 5.5 mg (95 % CI 4.1–6.3 mg), and 5.3 mg (95 % CI 3.7–6.2 mg) in Groups B, BE1, and BE2, respectively. The incidence of tourniquet pain was significantly lower in Groups BE1 and BE2 than in Group B. The time to patients’ requests for supplemental analgesia was significantly longer in Groups BE1 and BE2 than in Group B. Conclusions Intrathecal epinephrine did not decrease the dose of intrathecal hyperbaric bupivacaine required for successful anesthesia. However, it reduced the dose required for tourniquet pain blockade.
ISSN:0913-8668
1438-8359
DOI:10.1007/s00540-012-1471-x